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ABSTRACT
Background: Myringoplasty is a common procedure in otorhinolaryngology. Many techniques with dif-
ferent complications and outcomes have been described, one of which is hyaluronic acid fat graft myr-
ingoplasty (HAFGM). This technique, as proposed by Saliba, uses fat tissue and hyaluronic acid discs.
The technique is relatively fast with a high success rate and low complications. However, what out-
comes can be expected when performed by other surgeons? In this paper, we report on the
technique’s success in our own hands.
Materials and methods: Based on Saliba’s protocol, we performed 86 HAFGMs by a transcanal
approach between 2012 and August 2014. However, our 70% success rate was significantly different
from Saliba’s 92% (p value 2.8e 05). We visited Saliba’s clinic in order to identify critical differences
between our approaches. We adapted the differences we found in our protocol and analysed another
50 HAFGMs performed afterwards, between October 2014 and December 2015.
Results: The success rate increased to 86–89%, this percentage is not different compared to Saliba’s
results (p value .25 and .54).
Conclusion: HAFGM is a reproducible technique in the hands of other surgeons, but critical following
of the surgical protocol is important.
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Introduction
Tympanic membrane perforation is a common problem in
otorhinolaryngology. Studies show that about 80% of perfo-
rations will close spontaneously [1]. For persistent perfora-
tions, many surgical techniques have been described to close
the tympanic membrane. Myringoplasty was already
described more than 500 years ago, but after the invention
of the microscope and the use of antibiotics its success rate
has dramatically improved [1].
The primary goal of myringoplasty is the closure of the
membrane and improvement of hearing as well as preven-
tion of recurrent middle ear infections. Closure can be
achieved by foreign body materials such as GelfoamVR , basic
fibroblast growth factor and AllodermVR . Autologous materi-
als such as perichondrium, cartilage, fascia and skin are
commonly used today [1–6]. The success rate of closure
depends on the type of graft material, surgical technique,
perforation size and location of the perforation.
In 2008, Saliba first published his research and results on
hyaluronic acid fat graft myringoplasty (HAFGM);
21 patients underwent surgery resulting in a closure rate of
81% [6]. Technical improvements in a larger series of
patients showed a 92% closure rate [7]. Hyaluronic acid
seems to play an important role in preventing dehydration
of the perforation edges and is therefore believed to prevent
fibrous tissue formation. It also stimulates acceleration and
migration of epithelial cells [7,8]. Fat tissue is a rich source
of growth factors, cytokines and stem cells and is known for
good tissue regeneration properties [9].
The original HAFG myringoplasty technique by Saliba is
performed under local anaesthesia in an outpatient clinic. In
brief, his surgical technique is as follows: after applying local
anaesthesia, the edges of the perforation are de-epithelial-
ized. About 1 cm3 of fat tissue is harvested just behind the
sternocleidomastoid muscle. Several pieces of GelfoamVR are
placed in the middle ear cavity and on top of that the fat
graft is placed. One or more pieces of hyaluronic acid film
are then placed on the fat graft in a way that the edges of
the perforation are fully covered. Finally the hyaluronic film
is covered with pieces of GelfoamVR soaked in ciprofloxacin
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and the ear canal is then filled with an ointment of bacitra-
cin/polymyxin.
Based on this protocol, we performed 86 myringoplasties
by a transcanal approach between 2012 and August 2014.
However, our 70% success rate was significantly different
from Saliba’s 92% (p value 2.8e 05). During visits to
Saliba’s clinic, we identified several differences between our
approaches that may have contributed to the discrepancy in
performance of the technique:
1. Saliba only performed surgery on ears that had no signs
of infection for at least 6 months before surgery. When
we corrected our data for this parameter, our success
rate increased to 82%.
2. Saliba soaked SurgifoamVR pieces with ofloxacin drops.
We started first with GelfoamVR soaked in Terra-Cortril
(Hydrocortisone, oxytetracycline and polymyxin B).
Since steroids can impair epithelial growth, we switched
to ofloxacin instead [10]. Since some articles describe a
slightly larger degradation time for SurgifoamVR com-
pared to GelfoamVR [11], we used MeroGelVR , because
Surgifoam is not available in the Netherlands. This
results in longer packing of the ear canal and better sup-
port of the fat graft in the middle ear. Daily application
of ofloxacin drops results in a moist environment and
thereby facilitates epithelial migration over the fat graft
[12–14].
3. The fat graft was harvested in the neck in the hair line,
and not just behind the sternocleidomastoid muscle. It
is important to use only fat tissue without contamin-
ation with fibrous tissue or hair follicles.
4. Instead of removing a full thickness ring around the
edge of the perforation, Saliba only lifted the outer epi-
thelial layer and with spoke-like movements brushed
the epithelial layer away from the perforation edges.
Only after instalment of the fat graft the epithelium was
gently replaced.
Materials and methods
We adapted our protocol for the differences mentioned
above and analysed another 50 HAFGMs performed
Figure 1. Our surgery protocol in 10 steps [15].
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afterward, between October 2014 and December 2015, both
under general anaesthesia and local anaesthesia. Figure 1
presents our current modified protocol [15]. In the case of
tympanosclerosis, sclerotic plaque was removed.
Statistical dependency was tested using the chi-square test
in R 3.2.2 and Fisher’s exact test when a field had less than
10 cases. An example of our procedure is shown in the pic-
tures below (Figure 2).
Results
We performed surgery in 50 patients, 25 men and 25
women (Table 1). Most of the patients underwent general
anaesthesia. In four patients, the middle ear was inflamed at
the time of surgery. In Table 1, we have presented all cases
as well as the results for the cases without middle ear infec-
tion. By adjusting our protocol we significantly improved
the success (p value¼ .04) to a rate of 86%. This rate was
no longer significantly different from Saliba’s performance
(p value 0.25). It increased to 89% if the cases with middle
ear infection were left out (compared with Saliba’s success p
value 0.54). Sixty per cent of our patients were children
under the age of 18 years. Seven patients were not success-
fully operated on, although their perforations were reduced
in size. Most of the patients had a grade I (small) or II
(medium) perforation [6,7]. Audiometry was performed
before and after surgery in 42 patients. Thirty-nine patients
showed an improvement of the air bone-gap with at least
10 dB (Table 1).
Discussion
Hyaluronic acid fat graft myringoplasty is a safe and easy
way for closure of the tympanic membrane. Success rates
are comparable with literature [7] and since this procedure
can be performed under local anaesthesia, more fragile
patients can also receive this treatment.
Four of our patients had an inflamed middle ear at the
time of surgery. We decided to publish the results of these
four inflamed ears as well, accepting the fact that wound
healing is less efficient in an inflamed environment [16].
Our success rate changed from 86% to 89% when these four
patients were excluded. Most of the perforations were grade
I or II in size, and four of the seven patients in which the
result of surgery was unsuccessful also had grade I and II
perforations. In those seven patients, all perforations were
Figure 2. (a) Grade III perforation just before start of surgery showing a not inflamed middle ear. (b) The epithelial layer is lifted up. (c) Several pieces of MeroGelVR
are placed in the middle ear cavity. (d) On top of the MeroGelVR , the harvested fat graft is placed. (e) Hyaluronic acid film is placed on the fat graft. (f) 6 weeks after
surgery: the tympanic membrane is closed.
Table 1. Patients characteristics.
Characteristics
Percentage
all (n¼ 50)
Without middle ear
inflammation (n¼ 46)
Male 50% (n ¼ 25) 48% (n ¼ 22)
Under 18 years 60% (n ¼ 30) 61% (n ¼ 28)
Right ear 58% (n ¼ 29) 59% (n ¼ 27)
Grade I perforation 29% (n ¼ 14) 30% (n ¼ 14)
Grade II perforation 53% (n ¼ 26) 52% (n ¼ 24)
Grade III perforation 12% (n ¼ 6) 13% (n ¼ 6)
Grade IV perforation [6,7] 6% (n ¼ 3) 4% (n ¼ 2)
Decrease air-bone gap 94% (n ¼ 47) 94% (n ¼ 43)
Success rate 86% (n ¼ 43) 89% (n ¼ 41)
Success rate per grade I: 79%
II: 96%
III: 67%
IV: 100%
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reduced in size. Two of them were eventually successfully
closed after a revision HAFGM procedure. Looking at the
three patients where no improvement in hearing was
observed we found that one patient already had no air-bone
gap before surgery, and for another patient we found during
surgery that the stapes footplate was fixed, which resulted in
a maximal air bone-gap of 50 dB. The third patient had an
inflamed middle ear.
Conclusion
HAFGM is a good and reliable surgical method in the out-
patient clinic. By changing some points in our protocol we
improved our success rate from 70% to 86–89% mimicking
the results of Saliba. HAFGM is a reproducible technique in
other surgeons’ hands, but critical following of the surgical
protocol is important.
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